Table II.
Controls
|
|||||
---|---|---|---|---|---|
Plasma | LEVs | MEVs | SEVs | Pure SEVs | |
Small RNA (ng) | 2.26±1.27 | 4.32±1.04 | 4.90±0.95 | 10.34±3.51 | 14.51±8.03 |
miRNA (ng) | 0.82±0.49 | 1.70±0.45 | 2.12±0.26 | 4.16±1.17 | 9.87±6.72 |
miRNA/small RNA (%) | 29.67±5.90 | 37.07±3.45 | 39.27±1.83 | 39.43±1.82 | 51.37±12.64 |
| |||||
PD patients
|
|||||
Plasma | LEVs | MEVs | SEVs | Pure SEVs | |
| |||||
Small RNA (ng) | 8.37±4.32 | 13.15±2.15 | 16.18±3.94 | 11.76±3.94 | 19.51±4.10 |
miRNA (ng) | 4.03±2.14 | 5.38±0.96 | 7.00±1.48 | 4.74±1.48 | 8.92±2.40 |
miRNA/small RNA (%) | 32.80±2.40 | 35.15±0.25 | 36.50±0.60 | 35.30±0.60 | 35.15±0.35 |
Values are mean ± SEM, n=3 for controls and n=2 for PD patients. Yield of small RNA and miRNA is calculated starting from the concentration (ng/µl) determined by the Small RNA Assay (Agilent). LEVs, large extracellular vesicles; MEVs, medium extracellular vesicles; SEVs, small extracellular vesicles.